Saturday, July 4, 2026

THE FINAL COUNTDOWN: Kim and Xi Finalize Joint Invasion Plans As Diplomacy Dies

North Korea's understated New Year's greeting to China hints at cooling relations, contrasting with warmer ties seen previously.

2026: A New Chapter in China-North Korea Relations – What You Need to Know

North Korea welcomes President Xi Jinping's visit, emphasizing the strengthening of North Korea-China friendly relations.

Matica BIOLABS Signs CMO with Jeongjin Bioscience for Mesenchymal Stem Cell Culture Media Production

Matica BIOLABS partners with Jeongjin Bioscience for stem cell media production and expands operations with Humic for drug development.

Tag: Phase 1 trials

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

LG Chem’s FMC-220: A Breakthrough Cancer Drug Targeting the p53 Y220C Mutation

LG Chem secures exclusive rights to FMC-220, a cancer drug targeting the p53 Y220C mutation, aiming for Phase 1 trials.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.